Stay updated on Switching to B/F/TAF in Virologically Suppressed Adults Clinical Trial
Sign up to get notified when there's something new on the Switching to B/F/TAF in Virologically Suppressed Adults Clinical Trial page.

Latest updates to the Switching to B/F/TAF in Virologically Suppressed Adults Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows Revision: v3.5.0, replacing the previous v3.4.3. This appears to be a minor version update with no impact on study details or navigation.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 in the revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded a new publication citation (Andreatta et al., J Antimicrob Chemother, 2019) with revision 3.4.1, and removed the Erratum reference for the same article (revision 3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe new screenshot shows the Study Details page with no additions or deletions to core content; the information on eligibility, endpoints, locations, and timeframes remains unchanged from the previous version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check72 days agoChange DetectedUI and metadata updates include a glossary toggle, the addition of 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' notes, and the revision label updated to v3.4.0 (replacing the older v3.3.4 variant).SummaryDifference0.1%

Stay in the know with updates to Switching to B/F/TAF in Virologically Suppressed Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switching to B/F/TAF in Virologically Suppressed Adults Clinical Trial page.